Karus Therapeutics presenting AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oxford, UK, 4 October 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving two poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 5-9 November 2015, Boston, USA.

The poster presentations are as follow:

  • Abstract B115 – Design and development of a novel series of PI3K-p110beta/delta-selective inhibitors with combined tumor immunotherapeutic, growth inhibition and anti-metastatic activity

    Presentation Time: Saturday, Nov 07, 2015, 12:30 PM – 3:30 PM
    Location: Session B, Hall C-D

  • Abstract A68 – Design and development of HDAC6-selective inhibitors for hematological cancer treatment and solid tumor immunotherapy

    Presentation Time: Friday, Nov 06, 2015, 12:15 PM – 3:15 PM
    Location: Session A, Hall C-D

For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.